|
Paul F. Reid PhD. is a Co-Founder of ReceptoPharm. From 1996 to May of 2001 Dr. Reid was an independent consultant to several privately held biotech companies where he used his expertise to assist in corporate development strategic planning which included writing business plans estimating market valuations for targeting potential venture capital and corporate partners and making presentations to U.S. and European financial institutions. Dr. Reid also advised his clients regarding human and veterinary regulatory affairs for the United States Canada and Europe and drug applications (pre IND IND and Orphan) drug production new drug development clinical trial design patient monitoring and experimental design. | 